DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Köse O, Zimmerhackl LB, Jungraithmayr T, Mache C, Nürnberger J.
New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
Semin Thromb Hemost 2010;
36 (6) 669-672
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.